2020
DOI: 10.1134/s160767292006006x
|View full text |Cite
|
Sign up to set email alerts
|

Prostate Cancer Growth Inhibition by 1-(3,5-Dimethylphenyl)–6-methyl-1H-pyrazolo[4,3-c]pyridin-4(5H)-one via Down-regulation of Phosphorylation PI3K/AKT and STA3/JAK2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…A previous study by Kharaziha et al reported that 22Rv1 cells exhibit constitutive activation of ERK1/2 and that its inhibition with the multi-tyrosine kinase inhibitor sorafenib induced cell death via activation of the pro-apoptotic protein Bad [ 54 ]. Likewise, the prooxidant agent 1-(3,5-dimethylphenyl)-6-methyl-1H-pyrazolo[4,3-c]pyridin-4 (5H)-one (DPMPP) exerted a cytotoxic effect in 22Rv1 cells by causing cell cycle arrest in S phase and apoptosis accompanied with an increase in the reactive oxygen species production and with an inhibition of the PI3K/AKT/ERK phosphorylation [ 55 ].…”
Section: Resultsmentioning
confidence: 99%
“…A previous study by Kharaziha et al reported that 22Rv1 cells exhibit constitutive activation of ERK1/2 and that its inhibition with the multi-tyrosine kinase inhibitor sorafenib induced cell death via activation of the pro-apoptotic protein Bad [ 54 ]. Likewise, the prooxidant agent 1-(3,5-dimethylphenyl)-6-methyl-1H-pyrazolo[4,3-c]pyridin-4 (5H)-one (DPMPP) exerted a cytotoxic effect in 22Rv1 cells by causing cell cycle arrest in S phase and apoptosis accompanied with an increase in the reactive oxygen species production and with an inhibition of the PI3K/AKT/ERK phosphorylation [ 55 ].…”
Section: Resultsmentioning
confidence: 99%